Gene expression data are accumulating exponentially in public repositories. Reanalysis and integration of themed collections from these studies may provide new insights, but requires further human curation.Here we report a crowdsourcing project to annotate and reanalyse a large number of gene expression profiles from Gene Expression Omnibus (GEO). Through a massive open online course on Coursera, over 70 participants from over 25 countries identify and annotate 2,460 single-gene perturbation signatures, 839 disease versus normal signatures, and 906 drug perturbation signatures. All these signatures are unique and are manually validated for quality. Global analysis of these signatures confirms known associations and identifies novel associations between genes, diseases and drugs. The manually curated signatures are used as a training set to develop classifiers for extracting similar signatures from the entire GEO repository. We develop a web portal to serve these signatures for query, download and visualization.
Genotipificación de los genes msp1 (bloque 2) y dhfr (codón108) de Plasmodium falciparum en muestras de campo recolectadas en cuatro localidades endémicas de Colombia Introducción. Plasmodium falciparum es un parásito altamente polimórfico, lo cual le permite evadir la respuesta inmune del hospedero, diseminar la resistencia a medicamentos y favorecer la transmisión. Objetivos. Analizar la diversidad genética de las poblaciones de P. falciparum en muestras de cuatro zonas endémicas de malaria en Colombia. Materiales y métodos. Se incluyeron muestras de sangre recolectadas en papel de filtro de 123 pacientes con malaria no complicada por P. falciparum durante los años 2002 a 2004; la genotipificación se realizó mediante reacción en cadena de la polimerasa con iniciadores específicos para los marcadores moleculares de la región polimórfica del bloque 2 del gen msp1 y del codón 108 de dhfr. Resultados. En el bloque 2 del gen msp1 se detectó MAD20 en 95,9% (118/123; IC 95%: 90,8 a 98,7), K1 en 6,5% (8/123; IC 95%: 2,8 a 12,4) y RO33 en 2,4% (3/123; IC 95%: 0,5 a 6,9) de las muestras. Para el gen dhfr, el alotipo mutante N108 se detectó en todas las muestras analizadas y el alotipo T108 en 3,2% (4/123; IC 95%: 0,9 a 8,1); el alotipo silvestre S108 se encontró en 34,1% (42/123; IC 95%: 25,8 a 43,2). Al combinar los resultados de ambos genes, el 61,8% (76/123; IC 95%: 52,6 a 70,4) de las muestras correspondieron a infecciones simples y el 38,2% (47/123; IC 95%: 29,6 a 47,4) a infecciones mixtas, siendo MAD20/N108-S108 la combinación más frecuente entre estas últimas (30,1%). Conclusiones. Las infecciones simples, o sea, la presencia de un solo alelo en cada uno de los genes, predominaron en las muestras estudiadas; las poblaciones de parásitos analizadas fueron muy homogéneas en su composición genética.Palabras clave: Plasmodium falciparum, PCR, variación (genética), polimorfismo (genética), Colombia. Genotyping of the Plasmodium falciparum msp1 (block 2) and dhfr (codon 108) genes in field samples collected in four endemic Colombian localitiesIntroduction. Plasmodium falciparum is a highly polymorphic parasite, which allows it to evade the host´s immune response, spread drug resistance and favours transmission. Objectives. To analyse the genetic diversity of P. falciparum populations in samples from four endemic localities in Colombia. Materials and methods. 123 blood samples were collected on filter paper from patients with non-complicated P. falciparum malaria during 2002 to 2004. The samples were genotyped using polymerase chain reaction with specific primers for the polymorphic region of block 2 of the msp1 gene and the 108 codon of the dhfr gene.Results. In msp1 block 2, 95.9% (118/123; 95% CI: 90.8-98.7) of the samples harboured MAD20; 6.5% K1 (8/123; 95% CI: 2.8-12.4) and 2.4% RO33 (3/123; 95% CI: 0.5-6.9). For the dhfr gene the mutant allele N 108 was found in all the samples amplified, T 108 in 3.2 % and the
CD94 forms heterodimers with NKG2A, -C, or -E to constitute lectin-like natural killer cell receptors for MHC-E. Its structure differs from other C-type lectins in that the second α-helix is replaced by a loop that forms the interacting interface with the NKG2 molecules. Although CD94 has remained highly conserved mammals, several alternative splicing variants have been detected in some species. To evaluate the prevalence and significance of this phenomenon, we have cloned and sequenced CD94 cDNAs in six species of New World primates from the Cebidae and Atelidae families. Full-length sequences had a mean similarity of 96 % amongst New World primates and of 90 % to the human orthologue, with little variation in the residues interacting with NKG2 or MHC-E molecules. Despite this high conservation, a total of 14 different splice variants were identified, half of which were shared by two or more primate species. Homology-based modeling of the C-type lectin domain showed that most isoforms folded stably, although they had modifications that prevented its interaction with NKG2 and MHC-E. Two isoforms were predicted to replace the typical CD94 loop by a second α-helix, evidencing a domain fold transition from a CD94 structure to a canonical C-type lectin. These two structures were more similar to members of the CLEC lectin family than to the native CD94. Thus, CD94 has remained conserved in primates to maintain functional interactions with NKG2 and MHC-E, while at the same time has diversified by alternative splicing potentially providing additional functional scenarios.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
hi@scite.ai
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.